What 5 Analyst Ratings Have To Say About Treace Medical Concepts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinions on Treace Medical Concepts (NASDAQ:TMCI) stock, with an average 12-month price target of $29.6. The current average has increased by 3.86% from the previous average price target of $28.50.
June 02, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Treace Medical Concepts (TMCI) has an average 12-month price target of $29.6, according to 5 analysts. The current average has increased by 3.86% from the previous average price target of $28.50.
The average 12-month price target for TMCI has increased by 3.86% from the previous average, indicating a positive sentiment among analysts. This could lead to a short-term increase in the stock price as investors may see this as a sign of potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100